16th Annual Outsourcing in Clinical Trials Europe 2026

Creating a collaborative environment where pharma & biotech leaders can find solutions to current challenges through innovations and partnerships

6 - 7

May

2026
  • Hyatt Regency Barcelona Tower, Barcelona, Spain
  • Complimentary
  • Why attend?
  • Agenda
  • Advisory Board
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • 2026 Sponsors
  • Media Centre
  • Why partner?
  • Resources
  • Contact Us
close

Featured Speakers

Back

Ken Getz​

Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

Ken is the Director of Sponsored Research and Associate Professor at the Tufts Center for the Study of Drug Development, and Chairman of the Center for Information and Study on Clinical Research Participation, a non-profit organization that he founded to raise public and patient awareness of the clinical research enterprise. He is founder and owner of CenterWatch, and an owner and board member of the Metrics Champion Consortium. A well-known speaker at symposia, universities, and corporations, Ken has published extensively in peer-reviewed journals, books and in the trade press.  He has been an active DIA member for 25 years and has held board appointments in the private and public sectors.  Ken earned his MBA from Northwestern University.

Next speaker
Back

Bernhard Glombitza​

PhD, Vice President, Head of Clinical Operations & Customer Engagement, EMEA & LATM, Bayer

With over 25 years of leadership experience in the pharmaceutical industry, I have consistently advanced in roles with increasing responsibilities in project and people management. From managing smaller-scale projects to leading the global Xarelto initiative with over 500 team members, my career is marked by significant achievements in operational excellence and innovation. As Vice President of Clinical Operations, I led teams >1000 FTE in 40 countries, have transformed organizational structures, boosting productivity by > 25% through strategic resource allocation and flattening hierarchies. Currently, I am pioneering initiatives to empower decentralized decision-making and enhance customer engagement in Clinical Operations EMEA/LATAM, this strategy contributed propelling us from the global position 7 to 1 (Top Sponser) in the CenterWatch site relation survey.
Driven by challenges and equipped with high learning agility, I am passionate about inspiring teams to explore their full potential in a psychologically safe environment.

Next speaker
Back

Emma Blasi Bosch​

Director, Global Regulatory Strategy, Alexion Pharmaceuticals

Emma has over 18 years of experience in the biopharmaceutical industry, spanning biotech startups, multinational companies and consultancy. She specializes in developing and implementing global regulatory strategies and successfully leading meetings with international regulatory agencies. As a global regulatory lead, she provides key insights to global programs focused on rare disease and oncology drug development, from first-in-human through late-phase clinical development and registration trials to successfully register unique, innovative, and technologically complex products.

 

Next speaker
Back

Rebeckha Magnusson​

Head of Clinical Operations & Quality Assurance, Ribcure

Next speaker
Back

Karin Nordbladh​

Director Clinical Operations, Alligator Bioscience

Karin has a MSc in Pharmacy and Pharmaceutical Biosciences from Uppsala University in Sweden.  She is passionate about drug development that aims to meet unmet medical needs. Karin has 19 years of experience in life science industry and has worked for Astra Zenica, McNeil AB, a Johnson&Johnson company, and currently works at Alligator Bioscience AB since 4 years as Dir ClinOps. Alligator is a company specialized in immune oncology drug development.

Next speaker
Back

Piotr Maslak​

Senior Director, Head of Emerging Technologies, AstraZeneca

Piotr Maślak is Senior Director and Head of Emerging Technologies at AstraZeneca. He leads global efforts to transform clinical trials with digital platforms and AI – accelerating development and making research more patient-centric. Piotr has a track record of scaling enterprise AI strategies and driving award-winning innovation. Recognized for driving digital transformation in pharmaceutical industry, he is passionate about challenging conventions and shaping the future of clinical research.

Next speaker

    2026 Sponsors Include:

    Back

    Company Information

    Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 35,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,300 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

    Company Website

    To learn more, please visit our website - https://www.medidata.com

    Next Sponsor
    Back

    Company Information

    ARENSIA Exploratory Medicine, a German-based company, is a leader in “first-in-patient” Phase IB and II/Proof-of-Concept clinical trials across a wide range of disease areas. With 14 proprietary research clinics and cutting-edge Phase I infrastructure, ARENSIA accelerates the early detection of efficacy signals for new therapies at an unparalleled speed. Its streamlined, highly efficient approach reduces patient recruitment time and costs by over 50% compared to conventional trial sites, which are often overcrowded and understaffed. This exceptional performance has resulted in a 93% repeat business rate and robust growth through collaborations with top pharmaceutical companies, biotechs, and global CROs. Headquartered in Düsseldorf, ARENSIA operates with a team of 600 professionals across 8 countries.

    Company Website

    To learn more, please visit our website - http://www.arensia-em.com/

    Next Sponsor
    Back

    Company Information

    ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employed approximately 41,150 employees in 113 locations in 53 countries as at September 30, 2022.

    Company Website

    To learn more, please visit our website - https://www.iconplc.com/sectors/biotech

    Next Sponsor
    Back

    Company Information

    IQVIA Technologies help you transform your clinical trials and improve patient safety with SaaS-based applications and tech-enabled services designed to streamline processes, improve workflows, and effectively engage and inform patients. The Orchestrated Clinical Trials (OCT) platform eases the burden on your sites and makes it easier and more appealing for patients to enroll and remain engaged, produces faster trials to database lock, and speeds time to market. For more information visit www.iqvia.com/oct or email us at OrchestrateYourTrials@iqvia.com

     

    Company Website

    To learn more, please visit our website - www.iqvia.com

    Next Sponsor
    Back

    Company Information

    Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug development. With deep therapeutic and regulatory expertise and an expansive global footprint across the Asia-Pacific region, North America, and Europe, Novotech offers clients an accelerated path to bring life-changing therapies to market.

    Company Website

    To learn more, please visit our website - www.novotech-cro.com

    Next Sponsor
    Back

    Company Information

    Worldwide is changing how the world experiences CROs – in the best possible way. From early phase, bioanalytical sciences, late phase, post-approval and real-world evidence, Worldwide Clinical Trials provides full-service drug development services for central nervous system, cardiovascular, metabolic, general medicine, oncology and rare disease therapies.

    Company Website

    To learn more, please visit our website - https://www.worldwide.com

    Next Sponsor
    Back

    Company Information

    PCM Trials has been at the forefront of decentralized clinical research since 2008, leading mobile visits and recently introducing community-based research sites. We are driving the shift to patient-centric clinical trials, giving individuals the flexibility to engage in research studies in ways that work best for them. Our approach expands opportunities for participation, resulting in greater patient diversity, reduced patient dropout, and faster study results.

    Company Website

    To learn more, please visit our website - http://www.pcmtrials.com/

    Next Sponsor
    Back

    Company Information

    1MED, is the leading European MedTech specialized solutions provider,
    offering end-to-end development expertise within the medical device, novel technology and combination products fields.

    Founded in 2014, with headquarter in Agno, Switzerland, and employing 100+ professionals across the Europe, 1MED’s mission is to support all the MedTech organizations in facing the complexity associated with the development of innovative medical devices in compliance with MDR.

    Such support may include providing preclinical support, regulatory advice, clinical study management, post marketing support, digital solutions and quality management systems across the clinical research continuum with a cross-functional approach which led to win the certification and certification maintenance of more than 500 different medical devices within the last 5 years.

    Company Website

    To learn more, please visit our website - https://www.1med.ch/

    Next Sponsor
    Back

    Company Information

    EMIS Recruit is an integrated solution that connects Research, Life Sciences and healthcare by embedding clinical research recruitment tools directly into the point of care systems.  EMIS recruit gives research organisations clear visibility of clinically relevant patients based on your study protocol. This enables us to provide you with qualified patients that streamline your recruitment process

    Next Sponsor
    Back

    Company Information

    Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company’s Net Promoter Score (NPS) consistently exceeds the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 1,000 trials across 80 countries.

    Company Website

    To learn more, please visit our website - https://www.suvoda.com/

    Next Sponsor

      Why attend?

      Arena International are delighted to announce Outsourcing in Clinical Trials Europe will be returning to Barcelona on the 6th – 7th May 2026!

      For the 16th Annual event, our flagship European clinical show will provide delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials.

      This conference will bring leading industry professionals together to share knowledge, with a focus on collaboration, advancing clinical development and concentrating on Clinical Operations, Data Management, AI, Innovation, and Technology.

      WHAT TO EXPECT FOR 2026?

      With regulations ever changing and the innovative advancements of technology rapidly growing, this conference will address the everyday and perspective challenges faced when working within the clinical trial space. Legislations such as the CTIS review to Generative AI and leveraging our global trial footprint to accelerate clinical development, as well as building on our new and existing relationships within our industry.

      This conference will bring industry professionals together to share knowledge, with a focus on collaboration, advancing clinical development and concentrating on clinical operations, innovation, technology and of course, patient centricity.

      This is a unique opportunity to network and share knowledge with the region’s leading pharmaceutical firms, biotech’s and medical device companies, to discuss operationally efficient, specifically targeted clinical trials. The 2026 program boasts 3 full streams complete with key content.

      Stream A: Outsourcing & Clinical Operations

      Stream B: AI, l Innovation & Technology

      Stream C Day 1: Biotech Strategy

      500+

      Attendees

      		80+

      Exhibitors

      		40+

      Speakers
      500+

      Attendees

      		80+

      Exhibitors
      40+

      Speakers

      Testimonials

      See What It's All About

      Agenda

      • 6 May 2026
      • 7 May 2026
      Expand All

      Streams

      Stream one

      Stream A: Clinical Operations and Outsourcing

      Stream two

      Stream B: AI & Tech Transformation

      Stream three

      Stream C: Biotech Strategy

      11:30 AM

      Embracing the unknown: Tips and tricks on how to grow your clinical operations

      • How to build the clin ops and QA in a biotech
      • Building a network to support your biotech through challenges
      • Identifying weak points and understanding what you need to progress
      • Balancing trust and control when navigating the unknown to curb risk and accelerate progression

      Speakers

      Rebeckha Magnusson
      Head of Clinical Operations & Quality Assurance, Ribcure

      12 PM

      Reserved for Event Sponsor

      12:30 PM

      Choosing the right CRO: key considerations for small biotech’s

      • Evaluating CRO capabilities and experience relevant to your specific therapeutic area and development stage
      • Balancing cost, quality and timelines within tight budget constraints
      • Negotiating contracts with flexibility to protect your biotech’s goals

      Speakers

      Neta Tobis
      Director of Clinical Operations, BiomX

      1 PM

      Lunch and networking

      2 PM

      PANEL DISCUSSION The biotech landscape in Europe 2026: growths, shifts and strategic outlook

      • Analysing current market dynamics and funding trends shaping biotech growth in 2026
      • Addressing ongoing talent shortages and evolving workforce strategies
      • Funding and investment for biotechs in various regions of Europe: how has this shifted in 2026?
      • The impact of national political and economic changes on the biotech landscape in Europe

      Moderator: Kate Dokukina, Head of Clinical Trials, Eilean Therapeutics

      Speakers

      Dr. Kate Dokukina
      Head of clinical trials, Eilean Therapeutics
      Michael Zörer
      Head of Clinical Operations, VarmX
      Karin Nordbladh
      Director Clinical Operations, Alligator Bioscience

      2:45 PM

      Reserved for Event Sponsor

      3:15 PM

      The Pursuit of Success: Driving your drug from the lab to the patient

      • Defining what do we do well & what could be improved – EU vs US focus
      • Planning & preparation within clinical trials – focus on phase 2/3
      • Choosing the right trial designs for new inpatient studies
      • How to achieve successful launch by building appropriate phase 3 program

      Speakers

      Dr. Kate Dokukina
      Head of clinical trials, Eilean Therapeutics

      3:45 PM

      Afternoon refreshments and networking

      4:15 PM

      Reserved for Event Sponsor

      4:45 PM

      Navigating the Evolving Biosimilars Landscape: Case Studies, EMA Guidance, and Implications for CROs

      • Learning from real-world case studies to accelerate biosimilar development and approval.
      • Understanding the EMA’s reflection paper and its role in shaping regulatory expectations.
      • Examining how a rapidly changing regulatory environment impacts development strategies.
      • Assessing the implications for CROs in supporting sponsors through this transition.

      Speakers

      Andreas Seidl
      Chief Scientific, Officer, Formycon

      5:30 PM

      Chairs closing remarks and Drinks Reception Sponsored by XXX

      11:30 AM

      Great expectations and how to meet them – Implementing AI into your study

      • Understanding stakeholder expectations for AI in clinical research
      • Practical steps for integrating AI into study design and operations
      • Ensuring data quality, transparency, and regulatory compliance
      • Measuring adoption, engagement, and return on investment from AI initiatives

      Speakers

      Dr. Fabian Kreimendahl
      Associate Director, Medical Evidence Biostatistics, Johnson & Johnson Innovation Medicine

      12 PM

      Reserved for Event Sponsor

      12:30 PM

      FIESDIE CHAT From Machine Insight to Manuel Review: AI for Vendor Proposals We will focus on

      Building out the RFI? What you outsource, what you need, and how many site visits? AI

      • Extracting and standardizing key details from unstructured vendor documents
      • Identifying inconsistencies, omissions, or gaps within proposals
      • Supporting decision-making while safeguarding confidentiality and protecting intellectual property contained in submissions
      • Case Study

      Moderator: Silvana Giro, Senior Management, Global Medical & Regulatory Affairs, Bracco Imaging

      Speakers

      Silvana Giro
      Responsible for Global Outsourcing & Contract Management Europe, Global Medical & Regulatory Affairs, Bracco Imaging
      Piotr Maslak
      Senior Director, Head of Emerging Technologies, AstraZeneca

      1 PM

      Lunch and networking

      2 PM

      PANEL DISCUSSION: The future of data management: Trends, technology and innovation

      • Overviewing current approaches and trends within clinical data management
      • Assessing challenges and identifying solutions
      • Understanding the where the industry is heading to curb competition

      Speakers

      Dr. Fabian Kreimendahl
      Associate Director, Medical Evidence Biostatistics, Johnson & Johnson Innovation Medicine

      2:45 PM

      Reserved for Event Sponsor

      3:15 PM

      Unlocking Efficiency in ClinicalTrials: Scaling eSource for Enhanced Data Management and Collaboration

      • It’s no longer a question whether digital transformation will happen—it is how fast we can scale it.
      • When innovations such as eSource/EHR-to-EDC operate at full swing, it will allow us to perform research that otherwise wouldn’t happen and to develop medicines that otherwise would never make it to the patient
      • Scaling up the technology opens new avenues for collaboration, involving pharmaceutical companies, hospitals, along with technology vendors and academic partners.

      Speakers

      Peter Casteleyn
      Clinical Data Strategy Advisor, The European Institute for Innovation Through Health Data (iHD)

      3:45 PM

      Afternoon refreshments and networking

      4:15 PM

      Reserved for Event Sponsor

      4:45 PM

      AI & SUSTAINABILITY SPOTLIGHT Scaling bio sample operations with AI – path to sustainability

      Automating bio sample logistics and enabling collaboration between stakeholders - sponsors, CROs, sites - through AI powered platforms with examples and discussing the role of AI in driving long term sustainability.

      Speakers

      Blanka Hezelova
      Associate Director, Precision Medicine Scientific Operations, Bioethics Coach, GSK

      5:30 PM

      Chairs closing remarks and Drinks Reception Sponsored by XXX

      8 AM

      Registration and refreshments

      8:45 AM

      Chairperson’s opening remarks

      Speakers

      Revati Tatake
      Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData Healthcare

      9 AM

      KEYNOTE Just how complex and inefficient are our clinical trials; and what can be done about it?

      • Empirical Data quantifying the magnitude of the problem
      • Identification of Opportunities to optimise protocol design and improve clinical trial performance
      • Case examples of strategies and their impact

      Speakers

      Ken Getz
      Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

      9:30 AM

      Reserved for Event Sponsor

      10 AM

      PANEL DISCUSSION New strategies to drive clinical trial efficiency and complicity

      • Opportunities most resonating within panel member companies
      • Strategies and tactics to address these opportunities
      • Implementation challenges and how to overcome them
      • Areas of future focus and opportunity

      Moderator: Ken Getz, Executive Director, Research Professor (PHCM), Tufts Center for the Study of Drug Development

      Speakers

      Ken Getz
      Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine
      Bernhard Glombitza
      PhD, Vice President, Head of Clinical Operations & Customer Engagement, EMEA & LATM, Bayer
      Estrella Garcia PhD
      Executive Director Global Clinical Operations, Almirall
      Joana Claverol Torres
      Clinical Research Director, Hospital Sant Joan de Déu, SJD Pediatric Cancer Center Barcelona
      Nicole Honigman
      Global Study Director, AstraZeneca

      10:30 AM

      Reserved for Event Sponsor

      11 AM

      Morning refreshments and networking break

      11:30 AM

      Reimaging Clinical Operations: Navigating the Future of Efficiency and innovation….an outlook into the year 2050

      Have you ever wondered what the future holds for clinical operations? Currently the industry is laser focused on decentralised trials, patient diversity, risk-based monitoring, real world evidence and digitalization but where, exactly, is all this going to lead? More importantly how can we prepare for what lies ahead? Based on experience, and market and business intelligence Bernhard will dare to give us a glimpse into the future by:

      • Exploring the challenges to come
      • Recommending solutions to implement now, in preparation for tomorrow

      Speakers

      Bernhard Glombitza
      PhD, Vice President, Head of Clinical Operations & Customer Engagement, EMEA & LATM, Bayer

      12 PM

      Reserved for Event Sponsor

      12:30 PM

      Global Regulatory Perspectives

      Gain insights from a Clinical Trials Global Regulatory Lead on navigating the evolving global regulatory landscape, from early development through to submission readiness.

      • Anticipating regulatory expectations and aligning strategies early in development
      • Integrating regulatory perspectives across Phase I–III to streamline approvals
      • Common challenges and proactive approaches in global filing preparation

      Speakers

      Emma Blasi Bosch
      Director, Global Regulatory Strategy, Alexion Pharmaceuticals

      1 PM

      Lunch and networking

      2 PM

      PANEL DISCUSSION GeoPolitical challenges beyond our control: How pharma and biotech companies in Europe can mitigate against this

      This session examines the impact of geopolitical uncertainty on clinical trials, supply chains, and market access in Europe. Experts will discuss practical strategies for risk management, operational resilience, and strategic planning, helping pharma and biotech companies navigate challenges beyond their control while maintaining continuity and compliance.

       

      Moderator: Revati Tatake, PhD, Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData

      Speakers

      Revati Tatake
      Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData Healthcare

      2:45 PM

      Reserved for Event Sponsor

      3:15 PM

      Revati Tatake

      Speakers

      Revati Tatake
      Global Head of Pharma Research, Analysis and Competitive Intelligence, GlobalData Healthcare

      3:45 PM

      Afternoon refreshments and networking

      4:15 PM

      Reserved for Event Sponsor

      4:45 PM

      PANEL DISCUSSION Choosing the Right Outsourcing Model for Your Clinical Trial

      • Overview of outsourcing models: Full-Service Outsourcing (FSO), Functional Service Provider (FSP), and in-house
      • Pros and cons of each model and how to select the best fit for your trial
      • When hybrid approaches (mixing outsourcing and in-house) are more effective than fully outsourcing or keeping trials fully internal
      • Understanding why FSP is gaining popularity among sponsors and how it can help meet trial timelines

      Moderator: Sonja Weiser, PhD, Senior Director, Clinical Operations, Insmed Germany

      Speakers

      Sonja Weiser
      PhD, Senior Director, Clinical Operations, Insmed Germany
      Eva Torres Costa
      Director, Alliance Management, AstraZeneca
      Rebeckha Magnusson
      Head of Clinical Operations & Quality Assurance, Ribcure

      5:30 PM

      Chairs closing remarks and Drinks Reception Sponsored by XXX

      Streams

      Stream one

      Stream A: Clinical Operations and Outsourcing

      Stream two

      Stream B: AI & Tech Transformation

      9 AM

      Keynote: Clinical trials in the age of AI – What you’ll discover

      Discover how artificial intelligence is transforming clinical research by streamlining processes from protocol design to regulatory submission. This session explores practical AI applications for overcoming recruitment challenges, ensuring ethical implementation, and shaping the future of oncology trials.

       

      • Overcome Bottlenecks: Learn how AI breaks cycle inefficiencies in trial design and patient screening.
      • Accelerate Recruitment: See how AI-driven models and molecular matching reduce screening time and failures.
      • Implement Ethically: Understand frameworks for bias mitigation, data privacy, and regulatory compliance.
      • Future Trends: Explore next-decade innovations like digital twins and foundation models.

       

      Speakers

      Eslam Katab
      Global Clinical Development Manager, Sandoz

      9:30 AM

      Reserved for Event Sponsor

      10 AM

      CISCRP Perceptions & Insights Case Study

      What Patients and the Public Think: Insights on AI and Tech in Trials

      As AI and emerging technologies reshape the clinical research landscape, understanding the perceptions and experiences of trial participants, patients, and the public is critical to building trust and improving trial success when these tools are used. Drawing on the latest CISCRP Perceptions & Insights bi-annual survey of over 12,000 respondents globally, this session explores concerns, expectations, and trial experiences on the use of AI and decentralized trial technologies. Practical approaches to the planning and use of these tools in research will also be shared, aligned with emerging patient-centric regulatory and good practice expectations.

      Speakers

      Behtash Bahador
      Senior Director, Community Engagement & Partnerships, CISCRP

      10:30 AM

      Reserved for Event Sponsor

      11 AM

      Morning refreshments and networking break

      11:45 AM

      Reserved for Event Sponsor

      12:15 PM

      AI Patient Crew – A Patient-led project for Involvement in AI Tool Design

      • Whose tool and for what purpose?
      • Risks and decisions
      • Health data and lifestyle information
      • Layers and interoperability

      Speakers

      Richard Stephens
      Patient Advocate and Project Leader., AI Patient Crew

      12:45 PM

      Lunch and networking

      2 PM

      Reserved for event sponsor

      2:30 PM

      PANEL DISCUSSION: Future of Clinical Trial Professionals: How Technology Is Transforming Workforce Roles and Expectations

      • Reimagining responsibilities across clinical trial functions in an AI- and automation-driven environment
      • Evolving from task-based roles to strategic, insight-driven contributors across operations and data functions
      • Redefining entry-level roles as technology reshapes foundational skills, expectations, and career pathways
      • Identifying the new capabilities required to ensure technology enhances, not replaces the expertise of clinical trial professionals

      Speakers

      Piotr Maslak
      Senior Director, Head of Emerging Technologies, AstraZeneca
      Eslam Katab
      Global Clinical Development Manager, Sandoz

      3:15 PM

      Afternoon refreshments and networking with Apple Prize Draw

      8 AM

      Registration and Breakfast Refreshments

      8:45 AM

      Chairperson’s opening remarks

      9 AM

      Implementing FDA’s Project Optimus in an ongoing trial – a case study

      Speakers

      Karin Nordbladh
      Director Clinical Operations, Alligator Bioscience

      9:30 AM

      Reserved for Event Sponsor

      10 AM

      CRO Governance 2.0: Lead, Align, Accelerate

      Speakers

      Eva Torres Costa
      Director, Alliance Management, AstraZeneca

      10:30 AM

      Reserved for Event Sponsor

      11 AM

      Morning refreshments and networking break

      11:45 AM

      Reserved for Event Sponsor

      12:15 PM

      CASE STUDY Pediatric Case Study: Insights for Faster, Safer Clinical Trials

      Paediatric trials bring amplified risks, tighter regulations, and higher stakes for patient safety - but the lessons learned extend far beyond children’s studies. In this case study, we examine the unique challenges of conducting a paediatric clinical trial and explore how its insights can be applied to improve planning, safety oversight, and operational efficiency in any therapeutic area.

      • Navigating Complex Risk Profiles: Managing safety, dosing, and ethical considerations in vulnerable populations.
      • Pharmacovigilance in Practice: Meeting rigorous monitoring and reporting demands under high scrutiny.
      • Recruitment and Engagement Strategies: Overcoming barriers to participation with patients, caregivers, and advocacy groups.
      • Transferable Takeaways: Applying lessons from paediatric research to accelerate and safeguard trials in all therapeutic areas.

      Speakers

      Joana Claverol Torres
      Clinical Research Director, Hospital Sant Joan de Déu, SJD Pediatric Cancer Center Barcelona

      12:45 PM

      Lunch and networking

      2 PM

      Reserved for event sponsor

      2:30 PM

      PANEL DISCUSSION Maximising Site Productivity: Reducing Burden and Strengthening Output

      As clinical trial protocols grow more complex, sites are under increasing pressure, juggling high workloads, limited resources, and administrative overload. This panel will explore practical strategies to optimise site performance, while acknowledging the real constraints they face today.

      We’ll examine:

      • The current challenges impacting site productivity
      • The consequences of site strain on trial delivery
      • Forward-thinking solutions to streamline operations and improve collaboration
      • Where electronic systems support, and where they still fall short

      Moderator: Sonja Weiser, PhD,Senior Director, Clinical Operations, Insmed Germany

      Speakers

      Sonja Weiser
      PhD, Senior Director, Clinical Operations, Insmed Germany
      Michael Zörer
      Head of Clinical Operations, VarmX
      Nicole Honigman
      Global Study Director, AstraZeneca
      Joana Claverol Torres
      Clinical Research Director, Hospital Sant Joan de Déu, SJD Pediatric Cancer Center Barcelona

      3:15 PM

      Afternoon refreshments and networking with Apple Prize Draw

      3:45 PM

      ROUNDTABLE DISCUSSIONS

      RT 1: Vendor Oversight in Complex Trials

      RT 2: AI and Vendor Proposals: Hype or Help?
      Silvana Giro, Senior Management, Global Medical & Regulatory Affairs, Bracco Imaging

      RT 3: Patient Engagement Tools That Actually Work
      Behtash Bahador, Senior Director, Community Engagement & Partnerships, CISCRP

      RT 4: Managing multi-country eConsent platforms

      RT 5: Key Takeaways of Project Optimus
      Karin Nordbladh, Director, Clinical Operation, Immune Oncology, Alligator Bioscience

      RT 6: Sustainability in Clinical Trials

      Speakers

      Silvana Giro
      Responsible for Global Outsourcing & Contract Management Europe, Global Medical & Regulatory Affairs, Bracco Imaging
      Behtash Bahador
      Senior Director, Community Engagement & Partnerships, CISCRP
      Karin Nordbladh
      Director Clinical Operations, Alligator Bioscience

      4:45 PM

      END OF CONFERENCE

      Speakers

      Select a speaker to learn more

      Back
      Ken Getz
      Executive Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

      Ken is the Director of Sponsored Research and Associate Professor at the Tufts Center for the Study of Drug Development, and Chairman of the Center for Information and Study on Clinical Research Participation, a non-profit organization that he founded to raise public and patient awareness of the clinical research enterprise. He is founder and owner of CenterWatch, and an owner and board member of the Metrics Champion Consortium. A well-known speaker at symposia, universities, and corporations, Ken has published extensively in peer-reviewed journals, books and in the trade press.  He has been an active DIA member for 25 years and has held board appointments in the private and public sectors.  Ken earned his MBA from Northwestern University.

      Session Details:

      PANEL DISCUSSION New strategies to drive clinical trial efficiency and complicity

      2026-05-06, 10:00 AM

      Session Details:

      KEYNOTE Just how complex and inefficient are our clinical trials; and what can be done about it?

      2026-05-06, 9:00 AM

      View In Agenda
      Next speaker
      Back
      Bernhard Glombitza
      PhD, Vice President, Head of Clinical Operations & Customer Engagement, EMEA & LATM, Bayer

      With over 25 years of leadership experience in the pharmaceutical industry, I have consistently advanced in roles with increasing responsibilities in project and people management. From managing smaller-scale projects to leading the global Xarelto initiative with over 500 team members, my career is marked by significant achievements in operational excellence and innovation. As Vice President of Clinical Operations, I led teams >1000 FTE in 40 countries, have transformed organizational structures, boosting productivity by > 25% through strategic resource allocation and flattening hierarchies. Currently, I am pioneering initiatives to empower decentralized decision-making and enhance customer engagement in Clinical Operations EMEA/LATAM, this strategy contributed propelling us from the global position 7 to 1 (Top Sponser) in the CenterWatch site relation survey.
      Driven by challenges and equipped with high learning agility, I am passionate about inspiring teams to explore their full potential in a psychologically safe environment.

      Session Details:

      PANEL DISCUSSION New strategies to drive clinical trial efficiency and complicity

      2026-05-06, 10:00 AM

      Session Details:

      Reimaging Clinical Operations: Navigating the Future of Efficiency and innovation….an outlook into the year 2050

      2026-05-06, 11:30 AM

      View In Agenda
      Next speaker
      Back
      Dr. Fabian Kreimendahl
      Associate Director, Medical Evidence Biostatistics, Johnson & Johnson Innovation Medicine

      Session Details:

      Great expectations and how to meet them – Implementing AI into your study

      2026-05-06, 11:30 AM

      Session Details:

      PANEL DISCUSSION: The future of data management: Trends, technology and innovation

      2026-05-06, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Rebeckha Magnusson
      Head of Clinical Operations & Quality Assurance, Ribcure

      Session Details:

      PANEL DISCUSSION Choosing the Right Outsourcing Model for Your Clinical Trial

      2026-05-06, 4:45 PM

      Session Details:

      Embracing the unknown: Tips and tricks on how to grow your clinical operations

      2026-05-06, 11:30 AM

      View In Agenda
      Next speaker
      Back
      Silvana Giro
      Responsible for Global Outsourcing & Contract Management Europe, Global Medical & Regulatory Affairs, Bracco Imaging

      From 1984 to 1988 employed by Ciba-Geigy, in the Sales Marketing of chemical products, within the Customer Services.

      Since 1988 employed by Bracco S.p.A. and then by Bracco Imaging S.p.A., developing different skills: Clinical Project Planning, Budget Control

      Since 2000 responsible for Contract Management in Europe, including contractual negotiation for all global functions within Global Medical & Regulatory Affairs.

      Since June 2002 also responsible for Global Outsourcing within Global Medical & Regulatory Affairs.

      Since 2001 Silvana Giro has been invited as speaker and moderator to several conferences and seminars.

      Session Details:

      FIESDIE CHAT From Machine Insight to Manuel Review: AI for Vendor Proposals We will focus on

      2026-05-06, 12:30 PM

      Session Details:

      ROUNDTABLE DISCUSSIONS

      2026-05-07, 3:45 PM

      View In Agenda
      Next speaker
      Back
      Neta Tobis
      Director of Clinical Operations, BiomX

      Session Details:

      Choosing the right CRO: key considerations for small biotech’s

      2026-05-06, 12:30 PM

      View In Agenda
      Next speaker
      Back
      Sonja Weiser
      PhD, Senior Director, Clinical Operations, Insmed Germany

      A Clinical Research Professional (Pharmacist), PhD (Medical School - Pharmacology/Toxicology) and PMP (2016) with more than 20 years’ experience in Biotech / Health Care Industry / CRO / Drug Development / Clinical Research.

      Expertise ranging from Clinical Research/Clinical Operations experience in Pharma, Biotech and CRO with focus on Oncology, Immunology, Infectious Disease, Respiratory indications and Rare/Orphan indications.

      Focused on goal achievement, constant striving for improving processes on an international / global level, strong project management background.

      Dedication to people management as the main success factor in clinical research/clinical development – foster open & trustful communication on a global level.

      Strong believer in "Manage by example" as key to success in drug development

      Session Details:

      PANEL DISCUSSION Choosing the Right Outsourcing Model for Your Clinical Trial

      2026-05-06, 4:45 PM

      Session Details:

      PANEL DISCUSSION Maximising Site Productivity: Reducing Burden and Strengthening Output

      2026-05-07, 2:30 PM

      View In Agenda
      Next speaker
      Back
      Peter Casteleyn
      Clinical Data Strategy Advisor, The European Institute for Innovation Through Health Data (iHD)

      Session Details:

      Unlocking Efficiency in ClinicalTrials: Scaling eSource for Enhanced Data Management and Collaboration

      2026-05-06, 3:15 PM

      View In Agenda
      Next speaker
      Back
      Blanka Hezelova
      Associate Director, Precision Medicine Scientific Operations, Bioethics Coach, GSK

      Blanka is an Associate Director within Precision Medicine Scientific Operations at GSK with over ten years of experience in research spanning from clinical site to sponsor roles, and expertise in biosample operations. She leads operational aspects of trials with a focus on innovation and excellence, successfully managing complex clinical studies while ensuring compliance and participant protection. Herf passion lies in ethical research and strategic improvements for operational efficiency.

      Session Details:

      AI & SUSTAINABILITY SPOTLIGHT Scaling bio sample operations with AI – path to sustainability

      2026-05-06, 4:45 PM

      View In Agenda
      Next speaker
      Back
      Andreas Seidl
      Chief Scientific, Officer, Formycon

      Session Details:

      Navigating the Evolving Biosimilars Landscape: Case Studies, EMA Guidance, and Implications for CROs

      2026-05-06, 4:45 PM

      View In Agenda
      Next speaker
      Back
      Eva Torres Costa
      Director, Alliance Management, AstraZeneca

      Session Details:

      PANEL DISCUSSION Choosing the Right Outsourcing Model for Your Clinical Trial

      2026-05-06, 4:45 PM

      Session Details:

      CRO Governance 2.0: Lead, Align, Accelerate

      2026-05-07, 10:00 AM

      View In Agenda
      Next speaker
      Back
      Behtash Bahador
      Senior Director, Community Engagement & Partnerships, CISCRP

      Behtash Bahador is the Senior Director of Community Engagement & Partnerships at the non-profit organization CISCRP, and holds a Master of Science in Health Communication from the Tufts University School of Medicine. Since 2014, he has collaborated with a range of stakeholder groups to establish and implement patient- and public-centric initiatives across the life-cycle of drug and treatment development. This has included supporting the development of regulatory and cross-disciplinary best practice guidelines, operationalizing key elements of evidence-based public health programing into research engagement activities, and always keeping the needs of patients, participants and the public at the forefront of his work.

      Session Details:

      CISCRP Perceptions & Insights Case Study

      2026-05-07, 10:00 AM

      Session Details:

      ROUNDTABLE DISCUSSIONS

      2026-05-07, 3:45 PM

      View In Agenda
      Next speaker
      Back
      Richard Stephens
      Patient Advocate and Project Leader., AI Patient Crew

      Session Details:

      AI Patient Crew – A Patient-led project for Involvement in AI Tool Design

      2026-05-07, 12:15 PM

      View In Agenda
      Next speaker
      Back
      Estrella Garcia PhD
      Executive Director Global Clinical Operations, Almirall

      Estrella began her ‘scientific odyssey’ at the University of Navarra, Spain, where she gained a PhD in Genetic Toxicology.  Following this, Estrella held at post-doctoral position at ICI (now Astra Zeneca) in Macclesfield, UK. At ICI Estrella’s focus was on novel anti-tumor drugs in the pre-clinical phase. Subsequently Estrella returned to Spain where she joined Almirall as a Clinical Research Scientist. Since then, Estrella has amassed a 29 year career with the company- taking on roles of increasing demand and responsibility, including Head of Allergy Therapeutic Area and Head of Clinical Development Operations- to the role she holds today.

      Estrella leads her group and is responsible for clinical trials worldwide. Since Almirall do not have affiliates fully involved in clinical development, the company externalizes all clinical trials, with a strategic focus on keeping only core competencies- particularly for pivotal studies- in-house. In this capacity Estrella has worked with dozens of CROs and service providers managing Phase I to Phase IV clinical trials of all sizes, from small single centre studies to global programs involving hundreds of sites and thousands of patients. Her responsibility is covering the selecting, negotiation, contracting, managing and final evaluation of the CROs responsible for the worldwide clinical development, in order to deliver on the agreed timelines, quality and cost.

      She has been responsible for ensuring Clinical Development for Aclidinium bromide in COPD was performed worldwide from the operational point of view on time, budget and quality, among other development from Almirall.

      Now fully focus on Dermatology development, managing trials worldwide mainly in Psoriasis, Acné, Atopic Dermatitis, Actinic Keratosis, among other indications.

      Session Details:

      PANEL DISCUSSION New strategies to drive clinical trial efficiency and complicity

      2026-05-06, 10:00 AM

      View In Agenda
      Next speaker
      Back
      Michael Zörer
      Head of Clinical Operations, VarmX

      Michael is responsible for a team of 11 people and the overall delivery of the conducted studies. The group runs several studies in different indications with a clear focus on rare diseases. In 2016 AOP Orphan received approval for one new product (RAPIBLOC®). In 2019 AOP received the marketing authorization for their first biological (BESREMi®), after completing a series of clinical studies and successfully passing a series of EMA inspections under Michael’s responsibility.

      Before joining AOP Orphan Michael has been operations manager for Haemophilia at Baxter. Michael has many years of experience as a project manager and learned the job in clinical research from scratch starting as CRA at Amgen. Michael received his Ph. D in biochemistry from the University of Vienna. 

      Session Details:

      PANEL DISCUSSION Maximising Site Productivity: Reducing Burden and Strengthening Output

      2026-05-07, 2:30 PM

      Session Details:

      PANEL DISCUSSION The biotech landscape in Europe 2026: growths, shifts and strategic outlook

      2026-05-06, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Karin Nordbladh
      Director Clinical Operations, Alligator Bioscience

      Karin has a MSc in Pharmacy and Pharmaceutical Biosciences from Uppsala University in Sweden.  She is passionate about drug development that aims to meet unmet medical needs. Karin has 19 years of experience in life science industry and has worked for Astra Zenica, McNeil AB, a Johnson&Johnson company, and currently works at Alligator Bioscience AB since 4 years as Dir ClinOps. Alligator is a company specialized in immune oncology drug development.

      Session Details:

      Implementing FDA’s Project Optimus in an ongoing trial – a case study

      2026-05-07, 9:00 AM

      Session Details:

      ROUNDTABLE DISCUSSIONS

      2026-05-07, 3:45 PM

      Session Details:

      PANEL DISCUSSION The biotech landscape in Europe 2026: growths, shifts and strategic outlook

      2026-05-06, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Dr. Kate Dokukina
      Head of clinical trials, Eilean Therapeutics

      Dr. Kate Dokukina is an expert with 20+ years in the biopharmaceutical industry and medicine , specializing in clinical research, drug development, and regulatory strategy. She has led global clinical programs across oncology, autoimmune, and rare diseases, overseeing the launch of 50+ new molecules. Currently VP in clinical trials at Eilean Therapeutics(US), she has held leadership roles at BIOCAD, Shanghai Pharma and MedInvestGroup.

      Session Details:

      The Pursuit of Success: Driving your drug from the lab to the patient

      2026-05-06, 3:15 PM

      Session Details:

      PANEL DISCUSSION The biotech landscape in Europe 2026: growths, shifts and strategic outlook

      2026-05-06, 2:00 PM

      View In Agenda
      Next speaker
      Back
      Emma Blasi Bosch
      Director, Global Regulatory Strategy, Alexion Pharmaceuticals

      Emma has over 18 years of experience in the biopharmaceutical industry, spanning biotech startups, multinational companies and consultancy. She specializes in developing and implementing global regulatory strategies and successfully leading meetings with international regulatory agencies. As a global regulatory lead, she provides key insights to global programs focused on rare disease and oncology drug development, from first-in-human through late-phase clinical development and registration trials to successfully register unique, innovative, and technologically complex products.

       

      Session Details:

      Global Regulatory Perspectives

      2026-05-06, 12:30 PM

      View In Agenda
      Next speaker
      Back
      Piotr Maslak
      Senior Director, Head of Emerging Technologies, AstraZeneca

      Piotr Maślak is Senior Director and Head of Emerging Technologies at AstraZeneca. He leads global efforts to transform clinical trials with digital platforms and AI – accelerating development and making research more patient-centric. Piotr has a track record of scaling enterprise AI strategies and driving award-winning innovation. Recognized for driving digital transformation in pharmaceutical industry, he is passionate about challenging conventions and shaping the future of clinical research.

      Session Details:

      FIESDIE CHAT From Machine Insight to Manuel Review: AI for Vendor Proposals We will focus on

      2026-05-06, 12:30 PM

      Session Details:

      PANEL DISCUSSION: Future of Clinical Trial Professionals: How Technology Is Transforming Workforce Roles and Expectations

      2026-05-07, 2:30 PM

      View In Agenda
      Next speaker
      Back
      Nicole Honigman
      Global Study Director, AstraZeneca

      Nicole Honigman is a proactive clinical research leader with 13+ years of experience driving Phase IIa–IV trials from feasibility through close-out across global and local settings. She currently serves as Global Study Director at AstraZeneca, where she leads cross-functional teams, oversees outsourced delivery, and steers study planning, risk‑based quality management, and inspection readiness to meet timelines, budgets, and quality standards. Previously at Alexion (AZ RDU), she led country operations and global monitoring oversight, optimizing startup, recruitment, vendor management, and CRA resourcing across complex rare disease programs. Nicole’s therapeutic expertise spans hematology, nephrology, neurology, bone metabolism, rheumatology, gastrointestinal, metabolic diseases, oncology, and infectious disease, with recent emphasis on cardiovascular trials. She is trained in project management, and recognized for disciplined TMF governance, KPI-driven performance management, and effective stakeholder communication.

      Session Details:

      PANEL DISCUSSION New strategies to drive clinical trial efficiency and complicity

      2026-05-06, 10:00 AM

      Session Details:

      PANEL DISCUSSION Maximising Site Productivity: Reducing Burden and Strengthening Output

      2026-05-07, 2:30 PM

      View In Agenda
      Next speaker
      Back
      Joana Claverol Torres
      Clinical Research Director, Hospital Sant Joan de Déu, SJD Pediatric Cancer Center Barcelona

      Joana Claverol , is the Clinical Research Director at Barcelona Children’s Hospital Sant Joan de Déu, Spain, where she leads the clinical trials office since 2012 and the Patients engagement in research area since 2015. The Clinical Research Unit is a reference unit for pediatric patients nationally and internationally, specializing in innovative treatments for highly complex patients with rare pediatric diseases. She has more than 13 years of experience in medical and clinical research in the pharmaceutical and biotechnology industry, with special knowledge and experience in drug development and clinical trial design, and all regulatory and methodological aspects related to clinical research. She holds a postgraduate in Senior Management Program of Health Institutions by IESE Business School, a Master in Pharmaceutical Marketing by Universitat Pompeu Fabra, a Master of clinical trials at Universitat de Barcelona and a BS Degree in Biological Sciences by Universitat Autonoma de Barcelona.

      Session Details:

      PANEL DISCUSSION New strategies to drive clinical trial efficiency and complicity

      2026-05-06, 10:00 AM

      Session Details:

      PANEL DISCUSSION Maximising Site Productivity: Reducing Burden and Strengthening Output

      2026-05-07, 2:30 PM

      Session Details:

      CASE STUDY Pediatric Case Study: Insights for Faster, Safer Clinical Trials

      2026-05-07, 12:15 PM

      View In Agenda
      Next speaker
      Back
      Eslam Katab
      Global Clinical Development Manager, Sandoz

      Session Details:

      PANEL DISCUSSION: Future of Clinical Trial Professionals: How Technology Is Transforming Workforce Roles and Expectations

      2026-05-07, 2:30 PM

      Session Details:

      Keynote: Clinical trials in the age of AI – What you’ll discover

      2026-05-07, 9:00 AM

      View In Agenda
      Next speaker

      Advisory Board

      Select a member to learn more

      Back
      Dr Alison McMorn
      PH.D – VP, CLINICAL DEVELOPMENT, AMO PHARMA LTD

      Dr. McMorn is an experienced clinical development researcher with over 25 years of industry experience and has a strong focus in CNS and paediatric drug development. She has worked for both Pharmaceutical Companies and Contract Research Organisations including holding positions at SAR Monitoring Services Ltd, Mundipharma International Ltd and Shire Development Inc. Starting her career at SAR as a Clinical Research Associate (CRA) she subsequently moved to Mundipharma where she was responsible for initiating the first paediatric clinical research program for the company. At Shire Dr. McMorn led, planned and managed global paediatric and adult clinical development programs for a wide variety of indications including psychiatry, pain, gastrointestinal and hepatology across all phases of development (Phase 0 to Phase 4). In addition she was responsible for harmonizing Clinical Trial Administrator (CTA) working practices across all regions for the company. In 2015 Dr. McMorn joined AMO Pharma Ltd, a virtual pharmaceutical company focused predominantly on paediatric neurodevelopmental rare diseases, as VP of Clinical Development. She holds an undergraduate degree in Pharmacology and a PhD in Psychology from the University of Leeds, UK.

      Next
      Back
      Behtash Bahador
      Senior Director, Community Engagement & Partnerships, CISCRP

      Behtash Bahador is the Senior Director of Community Engagement & Partnerships at the non-profit organization CISCRP, and holds a Master of Science in Health Communication from the Tufts University School of Medicine. Since 2014, he has collaborated with a range of stakeholder groups to establish and implement patient- and public-centric initiatives across the life-cycle of drug and treatment development. This has included supporting the development of regulatory and cross-disciplinary best practice guidelines, operationalizing key elements of evidence-based public health programing into research engagement activities, and always keeping the needs of patients, participants and the public at the forefront of his work.

      Session Details:

      CISCRP Perceptions & Insights Case Study

      2026-05-07, 10:00 AM

      Session Details:

      ROUNDTABLE DISCUSSIONS

      2026-05-07, 3:45 PM

      View In Agenda
      Next
      Back
      Kathleen Cohen
      Vice President, Clinical Development, Marinus Pharmaceuticals

      Kathleen Frenia Cohen is Vice President and Head of Clinical Development Operations at Marinus Pharmaceuticals.  Prior to joining Marinus, she spent 20+ years at PRA Health Sciences in a variety of project management and operational oversite roles. Kathleen graduated from the University of the Science in Philadelphia with a PharmD and completed a post-doctoral fellowship in Pharmacoeconomics and Outcomes Research from Rutgers College of Pharmacy. Kathleen resides in Media, PA.

      Next
      Back
      Aditya Kotta
      Head of Business Development, Novotech

      Aditya is the Regional Director of Business Development at Novotech, the Asia Pacific specialist CRO. He has extensive experience helping sponsor companies make their trials a reality across a range of projects from first in human to phase iv.

      Next
      Back
      Martin Rodriguez
      Consumer Safety & Evidence Global Quality & Excellence Head, Sanofi

      Senior executive Leader in Life Science (Biochemist) and Lean/Six Sigma Green-belt certified, with more than 20 year of experience in clinical operations, Operational Excellence (i.e., operational strategy, performance management, process optimization, risk management, Quality-by-Design and team performance), clinical quality, and Service Providers / Outsourcing management.

      I developed, reengineered, automated, and optimized business processes with a risk-based and approach to produce high quality outputs and to ensure regulatory compliance. I led the development, implementation and monitoring of different operational and quality strategies and models including Outsourcing as well as new/ innovative clinical capabilities to fulfill consumers/ patients needs .

      Next
      Back
      Rosie Filling
      Vice President, Senior Global Head R&D Operations, Endo
      Next
      Back
      Edwin van Vulpen
      Executive Director and Head of Clinical Business Development Euro-Asia
      Next

      Plan Your Visit

      Venue

      Hyatt Regency Barcelona Tower

      Avinguda de la Granvia de l’Hospitalet, 144 Barcelona, 08907 Spain

      Book Your Stay

      Accommodation

      Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. For the avoidance of doubt, Arena will only share attendee lists with carefully selected third party partners for event registration purposes. Whilst Arena International Events Group pursues third party agencies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group.

      2026 Sponsors

      Select a sponsor to learn more

      FEATURED SPONSORS

      SESSION SPONSORS

      TECHNOLOGY SHOWCASE SPONSORS

      Prize Draw Sponsor

      LANYARD SPONSOR

      Coffee Break Sponsor

      Lunch Sponsor

      Drinks Reception Sponsor

      EXHIBITORS

      Co-Sponsor

      Why partner?

      Contact us to become a partner

      Partnership Opportunities

      We work with you to design a bespoke package to meet your business needs, where you could:

      • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
      • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
        Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
      • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

      Event reach

      • 500+ attendees each year
      • 80% attendees C-suite level

       

      Take a look at our current sponsors

      Resources

      Media Centre

      Become a media partner

      A fantastic network of your peers and colleagues!

      See What It's All About

      Enquiry

      Contact Us

      SPONSORSHIP ENQUIRIES

      Ben Lloyd-Davies

      Commercial Director - Healthcare Events

      +61 280 978 126

      SPEAKER ENQUIRIES

      Maya Hudson

      Head of Production

      +44 (0) 204 540 7766

      MARKETING ENQUIRIES

      Hattie Dean

      Marketing Manager

      DELEGATE ENQUIRIES

      Sunny Saikia

      VIP Delegate Manager

      Sponsorship Enquiries

      To enquire about sponsorship opportunities for the conference, please contact:

      Ben Lloyd-Davies

      Commercial Director - Healthcare Events


      +44 207 8669 497

      Speaker Enquiries

      To enquire about speaking opportunities for the conference, please contact:

      Maya Hudson

      Head of Production


      +44 (0) 204 540 7766